Kanabo Group (LON:KNB) Sets New 12-Month Low – Here’s What Happened

Kanabo Group Plc (LON:KNB)’s stock price reached a new 52-week low on Tuesday . The stock traded as low as GBX 0.90 ($0.01) and last traded at GBX 1.20 ($0.02), with a volume of 143689 shares changing hands. The stock had previously closed at GBX 1.06 ($0.01).

Kanabo Group Stock Up 13.2 %

The business has a fifty day moving average price of GBX 1.16 and a two-hundred day moving average price of GBX 1.37. The company has a current ratio of 2.78, a quick ratio of 24.36 and a debt-to-equity ratio of 3.49. The company has a market cap of £7.59 million, a price-to-earnings ratio of -120.00 and a beta of 3.04.

Insiders Place Their Bets

In related news, insider Ian Mattioli purchased 150,000 shares of the stock in a transaction dated Tuesday, August 27th. The shares were acquired at an average cost of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,952.62). Insiders own 37.01% of the company’s stock.

Kanabo Group Company Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.